Navigation Links
PharMEDium Elects William R. Spalding to Board of Directors
Date:8/25/2010

LAKE FOREST, Ill., Aug. 25 /PRNewswire/ -- David N. Jonas, Chairman and CEO of PharMEDium Healthcare Corporation announced the election of William R. Spalding to the company's Board of Directors.

Spalding is Co-founder and Principal of The Crawford Spalding Group, an advisory and management services firm that applies extensive operational, financial and transactional expertise to assist companies primarily in the healthcare services industry.  Jonas stated, "Bill's experience in the healthcare services industry and his expertise with respect to matters of strategy, corporate development, operations and governmental affairs equip him well to add value to PharMEDium as a member of our Board of Directors going forward.  He will be an asset."

Mr. Spalding's career experience includes EVP Strategy and Managed Care for CVSCaremark Inc., a Fortune 20 company, and Senior Partner in the Atlanta office of King & Spalding LLP, where he led the Private Equity & Investment Funds Practice and was a member of the firm's management committee.

PharMEDium is the national leading provider of pharmacy sterile intravenous admixture compounding services. The PharMEDium network of state licensed and federally registered compounding centers provides trusted solutions to hospitals throughout the United States. PharMEDium complies with all applicable state laws and FDA regulations, including USP Chapter <797>, and DEA requirements.  For more information on PharMEDium, visit www.pharmedium.com.


'/>"/>
SOURCE PharMEDium
Copyright©2010 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. GeoVax Labs, Inc. Selects Financial Relations Board as Investor Relations Counsel
2. Genzyme Corporation Selects Diplomat Specialty Pharmacy for 2008 Renagel Medicare Part D Assistance Program
3. Catalyst Biosciences Selects Drug Development Candidate in Factor VIIa Program for Hemophilia
4. CellCyte Genetics Corporation Selects Washington University School of Medicine to Perform Study on CellCytes Glycoprotein Products in Heart Attack Disease Model
5. Radius Selects First Preclinical Candidate From SARM Discovery Program for the Treatment of Muscle Loss and Other Musculoskeletal Conditions
6. Sarah Cannon Research Institute Selects OmniComm Systems Electronic Data Capture Solution, TrialMaster(TM), for Clinical Trials Management
7. Halozyme Therapeutics Announces Roche Begins Phase 1 Clinical Trial and Selects Fourth Exclusive Biologic Target
8. University of California Los Angeles Selects Velos eResearch
9. Spherix Elects New Independent Director, and Elects Chairman of the Board
10. Accent on Aesthetics Plastic Surgery Medical Center Selects Artefill to Meet Growing Patient Demand for a Longer Lasting Dermal Filler
11. Amarex Clinical Research Selects OmniComm Systems to Provide eClinical Solutions for Phase III Medical Device Study and Joins OmniComms CRO Preferred Program
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/24/2017)... IBM (NYSE: IBM ) has been recognized as a ... for the fourth year in a row. 1 ... the Leaders quadrant have the highest scores for their Ability ... Leaders quadrant has the market share, credibility, and marketing and ... These vendors demonstrate a clear understanding of market needs; they ...
(Date:7/21/2017)... and RESEARCH TRIANGLE PARK, N.C. ... Corporation (NASDAQ: UTHR ) announced today that ... before the market opens on Thursday, July 27, 2017. ... host a teleconference on Thursday, July 27, 2017, at ... dialing 1-877-351-5881, with international callers dialing 1-970-315-0533.  A rebroadcast ...
(Date:7/20/2017)... , July 20, 2017  Prime Therapeutics LLC (Prime) released ... , M.D., following today,s Institute for Clinical and Economic Review,s ... on the effectiveness and value of abuse-deterrent formulations (ADF) of ... policy roundtable at the meeting. ... material cost benefit to the use of abuse-deterrent formulations (ADF) ...
Breaking Medicine Technology:
(Date:7/26/2017)... ... July 26, 2017 , ... “We are thrilled to be partnering with ... to schedule an appointment online in real time,” said Keith English, LocalMed CEO. “Allowing ... directory will bring more Six Month Smiles patients to their providers.” , Each month, ...
(Date:7/26/2017)... ... July 26, 2017 , ... Isodiol ... global cannabis innovator, specializing in the development of pharmaceutical and consumer products, announces ... 2017 to June 30, 2017. Iso International LLC recorded unaudited fiscal Q1 profits ...
(Date:7/26/2017)... ... 26, 2017 , ... BioPlus Specialty Pharmacy (BioPlus), ... of the HCV Treatment Path app (version 4.4.0) to keep health care providers ... All of the latest HCV medications are included in this app, including Vosevi™ ...
(Date:7/25/2017)... , ... July 25, 2017 , ... Summers in Palm ... the air conditioner — think homemade gourmet ice cream, sparkling pools, and mile-high fun. ... shop featuring fun mugs, journals, and other must-have knick knacks. Ice cream and sorbet ...
(Date:7/25/2017)... ... July 25, 2017 , ... SureVest Insurance ... services to communities across North Carolina, is launching a charity event in conjunction ... support for the ongoing fight against bladder cancer. , The Bladder Cancer Advocacy ...
Breaking Medicine News(10 mins):